<DOC>
	<DOCNO>NCT01438593</DOCNO>
	<brief_summary>The purpose study determine safety possible effectiveness brain transplant CD34+ stem cell obtain umbilical cord blood ( UCB ) treat stroke .</brief_summary>
	<brief_title>Study Purified Umbilical Cord Blood CD34+ Stem Cell Chronic Ischemic Stroke</brief_title>
	<detailed_description>The study use CD34+ cell ( special kind cell believe stem cell ) isolate UCB ( blood obtain birth umbilical cord blood baby ) . StemCyte , lead accredit UCB bank company branch United States Taiwan , provide unit UCB match least 5 6 HLA ( human leukocyte antigen ) transplantation . The HLA-matching use match cell organs transplantation body reject cell . We isolate CD34 cell unit , purify , suspend cell solution ( 1 ml contain 2-8 million cell ) , inject cell brain around site damage stroke</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>1 . Subjects either gender must 35 75 year age . 2 . Subjects must ischemic stroke 6 less 60 month ago . 3 . Subjects must stable hemiplegia hemiparesis condition least 3 month . 4 . Subjects must strokeinduced clinical deficit affect motor , perceptual , language function , National Institutes Health Stroke Scale ( NIHSS ) 515 . 5 . Subjects must stroke middle cerebral artery territory . 6 . Subjects must available umbilical cord blood unit HLAmatch least 5:6 ( HLAA , B , DR ) . 7 . Subjects must able read understand inform consent form approve appropriate Institutional Review Board ( IRB ) . The subject must sign date inform consent form studyspecific procedure . ( Note : If subject consent participation position sign date inform consent form personally physical condition , consent form must confirm orally time consent , mark finger print subject voluntarily ) . The informed consent procedure must observe independent witness present throughout whole informed consent process sign consent form . 1 . Subject evidence nonischemic mechanism , subarachnoid hemorrhage , primary intracerebral intraventricular hemorrhage MRI show occlusion middle cerebral artery territory . 2 . Pregnant lactating woman . 3 . History alcohol drug abuse previous 3 month . 4 . Subjects must follow condition document : significant renal , cardiovascular , hepatic , psychiatric disease abnormal blood coagulation parameter , immunodeficiency ( e.g . AIDS ) tumor , leukemia , cancer may interfere clinical trial protocol infectious disease , include hepatitis , condition may contraindication planned therapy evaluation . 5 . Subject must currently participate another investigational study take investigational drug within last four week screen study . 6 . Any condition , opinion investigator , suggest subject would compliant study protocol would suitable perform surgery participate study .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Brain disease</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Cerebral infraction</keyword>
	<keyword>Cord Blood</keyword>
</DOC>